Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy

Cites (317)

Items 201–317 of 317

1. Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study
   Susanna Amadio, Cinzia Montilli, Barbara Picconi · 2007 · Purinergic Signalling
2. P2 receptors, microglial cytokines and chemokines, and neuropathic pain
   Makoto Tsuda · 2016 · Journal of Neuroscience Research
3. Purinergic contribution to amyotrophic lateral sclerosis
   Cinzia Volonté, Savina Apolloni, Chiara Parisi, Susanna Amadio · 2015 · Neuropharmacology
4. Mutant Protein Kinase Cγ Found in Spinocerebellar Ataxia Type 14 Is Susceptible to Aggregation and Causes Cell Death
   Takahiro Seki, Naoko Adachi, Yoshitaka Ono et al. · 2005 · Journal of Biological Chemistry
5. Adenosine A2A Receptors in Striatal Glutamatergic Terminals and GABAergic Neurons Oppositely Modulate Psychostimulant Action and DARPP-32 Phosphorylation
   Hai‐Ying Shen, Paula M. Canas, Patricia García‐Sanz, Jing‐Quan Lan, Detlev Boison, Rosario Moratalla, Rodrigo Antunes Cunha, Jiang‐Fan Chen · 2013 · PLoS ONE
6. P2Y12Receptor on the Verge of a Neuroinflammatory Breakdown
   Susanna Amadio, Chiara Parisi, Cinzia Montilli, Alberto Savio Carrubba, Savina Apolloni, Cinzia Volonté · 2014 · Mediators of Inflammation
7. Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome
   César Quiroz, Seema Gulyani, Wan Ruiqian, Jordi Bonaventura, Roy G. Cutler, Virginia Pearson, Richard P. Allen, Christopher J. Earley, Mark P. Mattson, Sergi Ferré · 2016 · Neuropharmacology
8. Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3‐nitropropionic acid‐induced striatal damage
   J. Stephen Fink, Anti Kalda, Hoon Ryu, Edward C. Stack, Michael A. Schwarzschild, Jiang‐Fan Chen, Robert J. Ferrante · 2003 · Journal of Neurochemistry
9. Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow
   Marco Gianfriddo, Alessia Melani, D. Turchi, Maria Grazia Giovannini, Felicita Pedata · 2004 · Neurobiology of Disease
10. Elucidating the role of the A2Aadenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs
    Feng‐Lan Chiu, Jun-Tasi Lin, Ching-Yu Chuang, Ting Chien, Chiung‐Mei Chen, Kai-Hsiang Stanley Chen, Han‐Yun Hsiao, Yow‐Sien Lin, Yijuang Chern, Hung‐Chih Kuo · 2015 · Human Molecular Genetics
11. Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum
    Estefanía Moreno, Anna Chiarlone, Mireia Medrano, Mar Puigdellívol, Lučka Bibič, Lesley A. Howell, Eva Resel, Nagore Puente, Marı́a José Casarejos, Juan Perucho et al. · 2017 · Neuropsychopharmacology
12. Microglia P2Y6 receptor is related to Parkinson’s disease through neuroinflammatory process
    Xiao-Dong Yang, Yue Lou, Guidong Liu, Xueping Wang, Yi-Wei Qian, Jian-Qing Ding, Sheng-Di Chen, Q. Xiao · 2017 · Journal of Neuroinflammation
13. Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington’s disease mice
    Maria Rosaria Domenici, María Luisa Scattoni, Alberto Martire, Giusi Lastoria, Rosa Luisa Potenza, Anna Borioni, Aldina Venerosi, Gemma Calamandrei, Patrizia Popoli · 2007 · Neurobiology of Disease
14. Adenosine modulates hypoxia‐induced responses in rat PC12 cells via the A2Areceptor
    Shuichi Kobayashi, Laura Conforti, Raymund Y.K. Pun · 1998 · The Journal of Physiology
15. BDNF heightens the sensitivity of motor neurons to excitotoxic insults through activation of TrkB
    Peter Hu, Robert Gordon Kalb · 2003 · Journal of Neurochemistry
16. The role of SMN in spinal muscular atrophy
    Sibylle Jablonka, Wilfried Rossoll, Berthold Schrank, Michael Sendtner · 2000 · Journal of Neurology
17. The Spinocerebellar Ataxias: Clinical Aspects And Molecular Genetics
    Antoni Matilla‐Dueñas, Marc Corral‐Juan, Vı́ctor Volpini, Ivelisse Sánchez · 2012 · Advances in experimental medicine and biology
18. Inhibitors of metabolism rescue cell death in Huntington's disease models
    Hemant Varma, Richard Cheng, Cindy Voisine, Anne C. Hart, Brent R. Stockwell · 2007 · Proceedings of the National Academy of Sciences
19. Mechanisms of Parkinson’s disease-related proteins in mediating secondary brain damage after cerebral ischemia
    TaeHee Kim, Raghu Vemuganti · 2017 · Journal of Cerebral Blood Flow & Metabolism
20. P2X7 receptor-pannexin 1 interaction mediates extracellular alpha-synuclein-induced ATP release in neuroblastoma SH-SY5Y cells
    Wilkaniec, Anna, Gąssowska, Magdalena, Czapski, Grzegorz A., Cieślik, Magdalena, Sulkowski, Grzegorz, Adamczyk, Agata · 2017 · Purinergic Signalling
21. Brain‐Derived Neurotrophic Factor Induces Excitotoxic Sensitivity in Cultured Embryonic Rat Spinal Motor Neurons Through Activation of the Phosphatidylinositol 3‐Kinase Pathway
    Hugh J.L. Fryer, Daniel H. Wolf, Ronald J. Knox, Stephen M. Strittmatter, Diane Pennica, Rhona M. O'Leary, David Russell, Robert Gordon Kalb · 2000 · Journal of Neurochemistry
22. Purinergic Signaling and Energy Homeostasis in Psychiatric Disorders
    Daniel M. Lindberg, Dan Shan, Jennifer R. Ayers-Ringler, Alfredo Oliveros, Julio Cesar Aguila Benitez, Miguel L. Prieto, Robert Erne McCullumsmith, Doo‐Sup Choi · 2015 · Current Molecular Medicine
23. Selective mitochondrial Ca 2+ uptake deficit in disease endstage vulnerable motoneurons of the SOD1 G93A mouse model of amyotrophic lateral sclerosis
    Andrea Fuchs, Sylvie Kutterer, Tobias Mühling, Johanna Duda, Burkhard Schütz, Birgit Liss, Bernhard U. Keller, Jochen Roeper · 2013 · The Journal of Physiology
24. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis
    Maria Andries, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch · 2006 · Neurobiology of Disease
25. Splicing regulation of the Survival Motor Neuron genes and implications for treatment of spinal muscular atrophy
    Thomas, W. Bebee · 2010 · Frontiers in bioscience
26. P2X7 receptor‐induced death of motor neurons by a peroxynitrite/ FAS ‐dependent pathway
    Mandi Gandelman, Mark Levy, Patricia Cassina, Luis Barbeito, Joseph S. Beckman · 2013 · Journal of Neurochemistry
27. Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis
    Rosa Luisa Potenza, Monica Armida, Antonella Ferrante, Antonella Pèzzola, Alessandra Matteucci, Maria Puopolo, Patrizia Popoli · 2013 · Journal of Neuroscience Research
28. Brain‐Derived Neurotrophic Factor Accelerates Nitric Oxide Donor‐Induced Apoptosis of Cultured Cortical Neurons
    Yasuyuki Ishikawa, Toshihiko Ikeuchi, Hiroshi Hatanaka · 2000 · Journal of Neurochemistry
29. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis
    Seng Kah Ng, Haruki Higashimori, Michaela Tolman, Yongjie Yang · 2015 · Experimental Neurology
30. Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis
    Hans Lassmann · 1983 · Journal of Neurology
31. Liposome-delivered superoxide dismutase prevents nitric oxide–dependent motor neuron death induced by trophic factor withdrawal
    Álvaro G. Estévez, Jacinda B. Sampson, Yingxin Zhuang, Nathan Spear, Gloria J. Richardson, John P. Crow, Margaret M. Tarpey, Luis Barbeito, Joseph S. Beckman · 2000 · Free Radical Biology and Medicine
32. Coffee and Amyotrophic Lateral Sclerosis: A Possible Preventive Role
    Ettore Beghi, Elisabetta Pupillo, Paolo Messina, Giorgia Giussani, Adriano Chiò, Stefano Zoccolella, Cristina Moglia, Massimo Corbo, Giancarlo Logroscino · 2011 · American Journal of Epidemiology
33. The P2X7 receptor links mechanical strain to cytokine IL ‐6 up‐regulation and release in neurons and astrocytes
    Wennan Lu, Farraj Albalawi, Jonathan M. Beckel, Jason Chu-Shern Lim, Alan M. Laties, Claire H. Mitchell · 2017 · Journal of Neurochemistry
34. When and how should treatment be started in Parkinson disease?
    Anthony Edward Lang · 2009 · Neurology
35. Residues 155 and 348 Contribute to the Determination of P2X7 Receptor Function via Distinct Mechanisms Revealed by Single-nucleotide Polymorphisms
    Helen Bradley, Jocelyn M. Baldwin, G. Ranjan Goli, Brian Johnson, Jie Zou, Asipu Sivaprasadarao, Stephen A. Baldwin, Lin‐Hua Jiang · 2011 · Journal of Biological Chemistry
36. Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy
    Qidi Hu, Xiangpeng Ren, Ya Liu, Zhihui Li, Liping Zhang, Xingjun Chen, Chaoxiang He, Jiang‐Fan Chen · 2016 · Experimental Neurology
37. Cerebellar lesion up-regulates P2X1 and P2X2 purinergic receptors in precerebellar nuclei
    Fulvio Florenzano, Maria Teresa Viscomi, Fabio Cavaliere · 2002 · Neuroscience
38. Amyotrophic lateral sclerosis and food intake
    Elisabetta Pupillo, Elisa Bianchi, Adriano Chiò, Federico Casale, Chiara Zecca, Rosanna Tortelli, Ettore Beghi, For Slalom, Parals, and for Slap Groups · 2017 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
39. Motor neuron–immune interactions: the vicious circle of ALS
    Ana G. Barbeito, Pinar Mesci, Séverine Boillée · 2010 · Journal of Neural Transmission
40. Clinical Phenomenology and Neuroimaging Correlates in ALS-FTD
    C. Lomen-Hoerth · 2011 · Journal of Molecular Neuroscience
41. Age at onset in Huntington’s disease: replication study on the associations of ADORA2A, HAP1 and OGG1
    Elahe Taherzadeh-Fard, Carsten Saft, Stefan Wieczorek · 2010 · Neurogenetics
42. A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease
    Stéphane Mievis, David L Blum, Catherine A. Ledent · 2010 · Neurobiology of Disease
43. The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis
    Elham Safarzadeh, Farhad Jadidi‐Niaragh, Morteza Motallebnezhad, Mehdi Yousefi · 2016 · Inflammation Research
44. Regulation of death and survival in astrocytes by ADP activating P2Y1 and P2Y12 receptors
    Liaman K. Mamedova, Zhan‐Guo Gao, Kenneth A. Jacobson · 2006 · Biochemical Pharmacology
45. Purinergic signaling in microglia in the pathogenesis of neuropathic pain
    Kazuhide Inoue · 2017 · Proceedings of the Japan Academy Series B
46. Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies
    Elinor Fondell, Éilis J. O’Reilly, Kathryn C. Fitzgerald, Guido J. Falcone, Laurence N. Kolonel, Yikyung Park, Susan M. Gapstur, Alberto Ascherio · 2015 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
47. Glutamate and ATP at the Interface Between Signaling and Metabolism in Astroglia: Examples from Pathology
    Vladimir Parpura, Elizabeth S. Fisher, James Donald Lechleiter, Arne Schousboe, Helle S. Waagepetersen, Sylvain Brunet, Selva Baltan, Alexei Verkhratsky · 2016 · Neurochemical Research
48. In search of alternatives to dopaminergic ligands for the treatment of restless legs syndrome: iron, glutamate, and adenosine
    Sergi Ferré, Christopher J. Earley, Seema Gulyani, Diego Garcı́a-Borreguero · 2016 · Sleep Medicine
49. The Human T Cell Response to Myelin Oligodendrocyte Glycoprotein: A Multiple Sclerosis Family-Based Study
    Niklas K. U. Koehler, Claude P. Genain, Barbara S. Giesser, Stephen L. Hauser · 2002 · The Journal of Immunology
50. Aberrant activation of AMP‐activated protein kinase contributes to the abnormal distribution of HuR in amyotrophic lateral sclerosis
    Yu‐Ju Liu, Li-Ming Lee, Hsing‐Lin Lai, Yijuang Chern · 2015 · FEBS Letters
51. Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: Comparison with the dopamine receptor imaging
    Kiichi Ishiwata, Nobuo Ogi, Nobutaka Hayakawa · 2002 · Annals of Nuclear Medicine
52. Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice
    Alberto Martire, Gemma Calamandrei, Fabio Felici · 2007 · Neuroscience Letters
53. Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease
    Shiraz Tyebji, Ana Saavedra, Paula M. Canas, Anna Pliássova, Jose Maria Delgado-Garcia, Jordi Alberch, Rodrigo Antunes Cunha, Agnès Gruart, Esther Pérez‐Navarro · 2014 · Neurobiology of Disease
54. Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death
    Davide Lecca, Stefania Ceruti, Marta Fumagalli, Maria P. Abbracchio · 2012 · Purinergic Signalling
55. Activation of P2X7 receptors decreases glutamate uptake and glutamine synthetase activity in RBA‐2 astrocytes via distinct mechanisms
    Jun‐Chih Lo, Wei‐Chi Huang, Yun‐Chia Chou, Chun-Hsien Tseng, Wei‐Li Lee, Synthia H. Sun · 2007 · Journal of Neurochemistry
56. Brilliant Blue G, but not Fenofibrate, Treatment Reverts Hemiparkinsonian Behavior and Restores Dopamine Levels in an Animal Model of Parkinson's Disease
    E. Ferrazoli, H. D. N. de Souza, I. Nascimento, Á. Oliveira-Giacomelli, T. T. Schwindt, L. Britto, H. Ulrich · 2017 · Cell Transplantation
57. Linkage mapping of the spinal muscular atrophy gene
    Arthur H.M. Burghes, Susan E. Ingraham, Zsofia K�te-Jarai et al. · 1994 · Human Genetics
58. Clinical Neurogenetics
    Matthew B. Harms, Robert H. Baloh · 2013 · Neurologic Clinics
59. TrkB mediates BDNF-induced potentiation of neuronal necrosis in cortical culture
    H Kim · 2003 · Neurobiology of Disease
60. Role of Adenosine A 2A Receptors in Modulating Synaptic Functions and Brain Levels of BDNF: a Possible Key Mechanism in the Pathophysiology of Huntington's Disease
    Maria Teresa Tebano, Alberto Martire, Valentina Chiodi, Antonella Ferrante, Patrizia Popoli · 2010 · The Scientific World JOURNAL
61. Purinergic modulation of synaptic signalling at the neuromuscular junction
    Keith J. Todd, Richard Robitaille · 2006 · Pflügers Archiv - European Journal of Physiology
62. Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction
    Ming Gan, Simon Moussaud, Peizhou Jiang, Pamela J. McLean · 2014 · Neurobiology of Aging
63. Recruitment of a Cytoplasmic Chaperone Relay by the A2A Adenosine Receptor
    Christian Bergmayr, Patrick Thurner, Simon Keuerleber, Oliver Kudlacek, Christian Nanoff, Michael Freissmuth, Christian W. Gruber · 2013 · Journal of Biological Chemistry
64. Purinergic signalling in B cells
    Tomasz Przybyła, Monika Sakowicz‐Burkiewicz, Tadeusz Pawełczyk · 2018 · Acta Biochimica Polonica
65. Purinergic neuromuscular transmission in the gastrointestinal tract; functional basis for future clinical and pharmacological studies
    Marcel Jiménez, Père Clavé, Anna M. Accarino, Diana Gallego · 2014 · British Journal of Pharmacology
66. The intrastratial injection of an adenosine A2 receptor antagonist prevents frontal cortex EEG abnormalities in a rat model of Huntington's disease
    Rosaria Reggio, Antonella Pèzzola, Patrizia Popoli · 1999 · Brain Research
67. A 2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients
    Fabrizio Vincenzi, Carmen Corciulo, Martina Targa, Ilaria Casetta, Mauro Gentile, Enrico Granieri, Pier Andrea Borea, Patrizia Popoli, Katia Varani · 2013 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
68. The Second Transmembrane Domain of P2X7 Contributes to Dilated Pore Formation
    Chengqun Sun, Michelle E. Heid, Peter A. Keyel, Russell D. Salter · 2013 · PLoS ONE
69. Caffeine Interaction with Glutamate Receptor Gene GRIN2A: Parkinson's Disease in Swedish Population
    Naomi Yamada-Fowler, Mats G. Fredrikson, Peter Söderkvist · 2014 · PLoS ONE
70. Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson’s Disease
    Krystyna Gołembiowska, Jadwiga Wardas, Karolina Noworyta, Katarzyna Kamińska, Anna Maria Górska · 2013 · Neurotoxicity Research
71. Presynaptic inhibition of spontaneous acetylcholine release induced by adenosine at the mouse neuromuscular junction
    Silvana De Lorenzo, Mariela Veggetti, S Muchnik · 2004 · British Journal of Pharmacology
72. The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea
    Vittorio Maglione, Milena Cannella, Tiziana Martino, Antonio De Blasi, Luigi Frati, Ferdinando Squitieri · 2005 · Neuroscience Letters
73. Mechanism of Action of IFN‐β in the Treatment of Multiple Sclerosis
    Laura M. Airas, Jussi Niemelä, Gennady G. Yegutkin · 2007 · Annals of the New York Academy of Sciences
74. Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington's disease
    Vittorio Maglione, Patrizia Giallonardo, Milena Cannella, T. Martino, L. Frati, Ferdinando Squitieri · 2005 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
75. Adenosine A2A receptors modulate BDNF both in normal conditions and in experimental models of Huntington’s disease
    Rosa Luisa Potenza, Maria Teresa Tebano, Alberto Martire, Maria Rosaria Domenici, Rita Pepponi, Monica Armida, Antonella Pèzzola, Luisa Minghetti, Patrizia Popoli · 2007 · Purinergic Signalling
76. Purinergic neurone-glia signalling in cognitive-related pathologies
    Péter Illés, Alexei Verkhratsky · 2015 · Neuropharmacology
77. Knockout of P2Y12 aggravates experimental autoimmune encephalomyelitis in mice via increasing of IL-23 production and Th17 cell differentiation by dendritic cells
    Jiang Zhang, Zhenlong Li, Xuefei Hu, Qiong Su, Cong He, Jing Liu, Hua Ren, Min Qian, Junling Liu, Shufang Cui et al. · 2016 · Brain Behavior and Immunity
78. A 2A adenosine receptors control pancreatic dysfunction in high‐fat‐diet‐induced obesity
    Balázs Csóka, Gábor Törő, Joana Vindeirinho, Zoltán V. Varga, Balázs Koscsó, Zoltán H. Németh, Endre Kókai, Luca Antonioli, Mara Suleiman, Piero Marchetti et al. · 2017 · The FASEB Journal
79. A2A Adenosine Receptor Facilitation of Neuromuscular Transmission
    Paulo Correia‐de‐Sá, M. Alexandrina Timóteo, Joaquim Alexandre Ribeiro · 2000 · Journal of Neurochemistry
80. Dual target strategy: combining distinct non‐dopaminergic treatments reduces neuronal cell loss and synergistically modulates l ‐ DOPA ‐induced rotational behavior in a rodent model of Parkinson's disease
    Marie‐Thérèse Armentero, Silvia Cerri, Giovanna Levandis et al. · 2015 · Journal of Neurochemistry
81. Modulation of phrenic motoneuron excitability by ATP: consequences for respiratory-related output in vitro
    Gareth Brian Miles, Marjorie A. Parkis, Janusz Lipski · 2002 · Journal of Applied Physiology
82. Up-regulation of P2X7 receptors mediating proliferation of Schwann cells after sciatic nerve injury
    Xianmin Song, Xiaohui Xu, Jiao Zhu, Zhili Guo, Jian Li, Cheng He, Geoffrey Burnstock, Hongbin Yuan, Zhenghua Xiang · 2015 · Purinergic Signalling
83. Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis
    Mariantonietta Caragnano, Paola Tortorella, Alessandra Bergami, Maddalena Ruggieri, Paolo Livrea, Luigi Maria Specchio, Gianvito Martino, María Trojano, Roberto Furlan, Carlo Avolio · 2012 · Journal of Neuroimmunology
84. Association of P2X7 receptor gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population
    Hongxin Liu, Xun Han, Yongsheng Li, Haiqiang Zou, Anmu Xie · 2013 · Neuroscience Letters
85. Caffeine alleviates progressive motor deficits in a transgenic mouse model of spinocerebellar ataxia
    Nélio Gonçalves, A. Simões, R. Prediger, H. Hirai, R. Cunha, Luís Pereira de Almeida · 2017 · Annals of Neurology
86. Caffeine, creatine, GRIN2A and Parkinson's disease progression
    David K. Simon, Cai Wu, Barbara C. Tilley, Katja Lohmann, Christine Klein, Haydeh Payami, Anne-Marie A. Wills, Michael J. Aminoff, Jacquelyn L. Bainbridge, Richard B. Dewey et al. · 2017 · Journal of the Neurological Sciences
87. Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission
    Filipe Nascimento, Ana Maria Sebastião, Joaquim Alexandre Ribeiro · 2015 · Purinergic Signalling
88. P2X7 receptor large pore signaling in avian Müller glial cells
    Robson Xavier Faria, Hércules Rezende Freitas, Ricardo Augusto de Melo Reis · 2017 · Journal of Bioenergetics and Biomembranes
89. In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease
    A. Vuorimaa, E. Rissanen, L. Airas · 2017 · Contrast Media & Molecular Imaging
90. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease
    María Luisa Scattoni, Angela Valanzano, Antonella Pèzzola · 2006 · Behavioural Brain Research
91. Adenosine A2A receptor and ERK-driven impulsivity potentiates hippocampal neuroblast proliferation
    Alfredo Oliveros, C H Cho, A Cui, Sung Hee Choi, Daniel M. Lindberg, David R. Hinton, M-H Jang, D-S Choi · 2017 · Translational Psychiatry
92. Purinergic receptor P2Y6 contributes to 1‐methyl‐4‐phenylpyridinium‐induced oxidative stress and cell death in neuronal SH‐SY5Y cells
    Yiwei Qian, Shaoqing Xu, Xiaodong Yang, Qin Xiao · 2017 · Journal of Neuroscience Research
93. Apyrase and 5′-nucleotidase Activities in Synaptosomes from the Cerebral Cortex of Rats Experimentally Demyelinated with Ethidium Bromide and Treated with Interferon-β
    Rosélia Maria Spanevello, Cinthia Melazzo de Andrade Mazzanti, Rosilene Rodrigues Kaizer et al. · 2006 · Neurochemical Research
94. Remodeling of striatal NMDA receptors by chronic A2A receptor blockade in Huntington's disease mice
    Alberto Martire, Antonella Ferrante, Rosa Luisa Potenza, Monica Armida, Roberta Ferretti, Antonella Pèzzola, Maria Rosaria Domenici, Patrizia Popoli · 2009 · Neurobiology of Disease
95. Differential effect of caffeine intake in subjects with genetic susceptibility to Parkinson’s Disease
    Prakash M. Kumar, Swe Swe Thet Paing, Huihua Li, R. Pavanni, Y. Yuen, Yirui Zhao, Eng King Tan · 2015 · Scientific Reports
96. Supportive or detrimental roles of P2Y receptors in brain pathology?—The two faces of P2Y receptors in stroke and neurodegeneration detected in neural cell and in animal model studies
    Daniel Förster, Georg Reiser · 2015 · Purinergic Signalling
97. α-Synuclein is a pathological link and therapeutic target for Parkinson’s disease and traumatic brain injury
    Md Shahaduzzaman, Sandra Acosta, Paula C. Bickford, Cesar V. Borlongan · 2013 · Medical Hypotheses
98. Expression of purinergic P2X(7) receptor in rat brain during the symptomatic phase of experimental autoimmune encephalomyelitis and after recovery of neurological deficits
    Tomasz Grygorowicz, Dorota Sulejczak, Lidia Strużyńska · 2011 · Acta Neurobiologiae Experimentalis
99. Motor neuropathies and lower motor neuron syndromes
    Annie Verschueren · 2017 · Revue Neurologique
100. Adenosine A2A receptor antagonist istradefylline 20 versus 40 mg/day as augmentation for Parkinson’s disease: a meta-analysis
     Chuan Jiang Zhu, Guowei Wang, Jinqing Li, Li Chen, Chaoli Wang, Yajie Wang, Ping Lin, Hong Ran · 2014 · Neurological Research
101. Diminished iron concentrations increase adenosine A2A receptor levels in mouse striatum and cultured human neuroblastoma cells
     Seema Gulyani, Christopher J. Earley, Simonetta Camandola, Stuart R. Maudsley, Sergi Ferré, Mohamed R. Mughal, Bronwen Martin, Aiwu Cheng, Marc Gleichmann, Byron C. Jones et al. · 2008 · Experimental Neurology
102. Spinal Cord
     Kourosh Rezania, Raymond P. Roos · 2012 · Neurologic Clinics
103. Adenosine A2A antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington’s disease
     Marco Gianfriddo, Claudia Corsi, Alessia Melani · 2003 · Brain Research
104. Influence of CGS 21680, a selective adenosine A2A receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice
     Antonella Ferrante, Alberto Martire, Monica Armida, Valentina Chiodi, Antonella Pèzzola, Rosa Luisa Potenza, Maria Rosaria Domenici, Patrizia Popoli · 2010 · Brain Research
105. Purinergic signaling and the functioning of the nervous system cells
     Kamila Puchałowicz, Irena Baranowska‐Bosiacka, Violetta Dziedziejko, Dariusz Chlubek · 2015 · Cellular & Molecular Biology Letters
106. Pathway for Parkinson disease
     Quyen Q. Hoang · 2014 · Proceedings of the National Academy of Sciences
107. Schwann cells are activated by ATP released from neurons in an in vitro cellular model of Miller Fisher syndrome
     Umberto Rodella, Samuele Negro, Michele Scorzeto, Elisanna Bergamin, Kees Jalink, Cesare Montecucco, Nobuhiro Yuki, Michela Rigoni · 2017 · Disease Models & Mechanisms
108. Functional changes in postsynaptic adenosine A2A receptors during early stages of a rat model of Huntington disease
     Marco Orrù, Janaína Menezes Zanoveli, César Quiroz · 2011 · Experimental Neurology
109. Mechanism of phagocytosis by Schwann cells
     Hamid Band, Alok Bhattacharya, Gursaran Parshad Talwar · 1986 · Journal of the Neurological Sciences
110. Parkinson's Disease
     K. A. Jellinger · 2011
111. The Adenosine Receptor Agonist, APNEA, Increases Calcium Influx into Rat Cortical Synaptosomes through N-Type Channels Associated with A2a Receptors
     Shengnan Li, Peter T.‐H. Wong · 2000 · Neurochemical Research
112. Excitatory effect of the A2A adenosine receptor agonist CGS-21680 on spontaneous and K+-evoked acetylcholine release at the mouse neuromuscular junction
     Alejandra Graciela Palma, S Muchnik, Adriana S. Losavio · 2010 · Neuroscience
113. Partial resistance of ataxin-2-containing olivary and pontine neurons to axotomy-induced degeneration
     Maria Teresa Viscomi, Fulvio Florenzano, Susanna Amadio · 2005 · Brain Research Bulletin
114. Functional changes in vascular reactivity to adenosine receptor activation in type I diabetic mice
     Hicham Labazi, Bunyen Teng, S. Jamal Mustafa · 2017 · European Journal of Pharmacology
115. Postsynaptic Potentiation in Mouse Motor Synapses Induced by ATP Accumulation in Synaptic Cleft
     Polina O. Bogacheva, Olga P. Balezina · 2015 · Bulletin of Experimental Biology and Medicine
116. Effect of adenosine receptor agonists on neurodegenerative and convulsive activity of mitochondrial toxin, 3-nitropropionic acid.
     Beata Zuchora, Ewa M. Urbańska · 2002 · PubMed
117. Neuropeptide changes in the suprachiasmatic nucleus in primary hypertension indicate functional impairment of the biological clock
     Goncharuk · 2001 · Pure Amsterdam UMC